Basic monocyclic compounds having Nk2 antagonist action, processes for their preparation, and formulations containing them
US7015196B1 · kind B1 · utility
3Cited by
0References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 17, 2000 |
| Grant date | Mar 21, 2006 |
| Priority date | — |
| Expiry date | Jan 21, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Basic monocyclic compounds having general formula (I) useful as NK-2 antagonists are described, processes for their preparation and pharmaceutical compositions containing them are also described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.